chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: Arm soreness; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness) and FATIGUE (Fatigue) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041B21A and 003A21A) for COVID-19 vaccination.     Concurrent medical conditions included Headache (had headache prior to vaccine).   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness) and FATIGUE (Fatigue). The patient was treated with IBUPROFEN on 12-Apr-2021 for Headache, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm soreness) and FATIGUE (Fatigue) outcome was unknown.            No relevant concomitant medications were provided.  Reportedly, the patient took ibuprofen 90 minutes after the vaccine for a headache which he had prior to the vaccine. No treatment information (for the events) was provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Eye pain, Headache, Malaise, Myalgia
Clinical narrative: not feeling well; Night sweats; Throat soreness; sinus infection , nostril hurts; sinus pressure; aching near eye; Chills; Fever; headache; Myalgia; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (not feeling well), NIGHT SWEATS (Night sweats), OROPHARYNGEAL PAIN (Throat soreness), SINUSITIS (sinus infection , nostril hurts) and PARANASAL SINUS DISCOMFORT (sinus pressure) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (not feeling well), NIGHT SWEATS (Night sweats), OROPHARYNGEAL PAIN (Throat soreness), SINUSITIS (sinus infection , nostril hurts), PARANASAL SINUS DISCOMFORT (sinus pressure), EYE PAIN (aching near eye), CHILLS (Chills), PYREXIA (Fever), HEADACHE (headache) and MYALGIA (Myalgia). At the time of the report, MALAISE (not feeling well), NIGHT SWEATS (Night sweats), OROPHARYNGEAL PAIN (Throat soreness), SINUSITIS (sinus infection , nostril hurts), PARANASAL SINUS DISCOMFORT (sinus pressure), EYE PAIN (aching near eye), CHILLS (Chills), PYREXIA (Fever), HEADACHE (headache) and MYALGIA (Myalgia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications and treatment information were not provided. No treatment medications were reported   This case was linked to MOD-2021-075012 (E2B Linked Report).; Sender's Comments:  MOD-2021-075012:
Sex: F
Vaccine: COVID19
Symptoms: Night sweats, Oropharyngeal pain, Paranasal sinus discomfort, Pyrexia, Sinusitis
Clinical narrative: not feeling well; Night sweats; Throat soreness; sinus infection , nostril hurts; sinus pressure; aching near eye; Chills; Fever; headache; Myalgia; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (not feeling well), NIGHT SWEATS (Night sweats), OROPHARYNGEAL PAIN (Throat soreness), SINUSITIS (sinus infection , nostril hurts) and PARANASAL SINUS DISCOMFORT (sinus pressure) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (not feeling well), NIGHT SWEATS (Night sweats), OROPHARYNGEAL PAIN (Throat soreness), SINUSITIS (sinus infection , nostril hurts), PARANASAL SINUS DISCOMFORT (sinus pressure), EYE PAIN (aching near eye), CHILLS (Chills), PYREXIA (Fever), HEADACHE (headache) and MYALGIA (Myalgia). At the time of the report, MALAISE (not feeling well), NIGHT SWEATS (Night sweats), OROPHARYNGEAL PAIN (Throat soreness), SINUSITIS (sinus infection , nostril hurts), PARANASAL SINUS DISCOMFORT (sinus pressure), EYE PAIN (aching near eye), CHILLS (Chills), PYREXIA (Fever), HEADACHE (headache) and MYALGIA (Myalgia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications and treatment information were not provided. No treatment medications were reported   This case was linked to MOD-2021-075012 (E2B Linked Report).; Sender's Comments:  MOD-2021-075012:
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Atrial flutter, Dyspnoea, Dyspnoea exertional
Clinical narrative: Subtle fluttering in her chest; Shortness of breath; shortness of breath with increased activity; This spontaneous case was reported by a nurse and describes the occurrence of ATRIAL FLUTTER (Subtle fluttering in her chest), DYSPNOEA (Shortness of breath) and DYSPNOEA EXERTIONAL (shortness of breath with increased activity) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 032L20A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81), FUROSEMIDE, SPIRONOLACTONE, OMEPRAZOLE, BIFIDOBACTERIUM INFANTIS (ALIGN), FISH OIL, VITAMIN D NOS, LIDOCAINE and PARACETAMOL (TYLENOL) for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced ATRIAL FLUTTER (Subtle fluttering in her chest), DYSPNOEA (Shortness of breath) and DYSPNOEA EXERTIONAL (shortness of breath with increased activity). At the time of the report, ATRIAL FLUTTER (Subtle fluttering in her chest), DYSPNOEA (Shortness of breath) and DYSPNOEA EXERTIONAL (shortness of breath with increased activity) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no treatment product was reported The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 2nd dose of Moderna vaccine administered on 22nd day; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose of Moderna vaccine administered on 22nd day) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose of Moderna vaccine administered on 22nd day). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose of Moderna vaccine administered on 22nd day) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Movement disorder, Peripheral swelling, Traumatic haematoma
Clinical narrative: Hospital claimed "I had hematoma"; My foot swelled up enormously; Couldn't put my foot down on the floor in the morning; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of TRAUMATIC HAEMATOMA (Hospital claimed "I had hematoma"), PERIPHERAL SWELLING (My foot swelled up enormously) and MOVEMENT DISORDER (Couldn't put my foot down on the floor in the morning) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 027A21A) for COVID-19 vaccination.     Concurrent medical conditions included Bruise (after a large shampoo bottle fell on left foot while taking shower) since 24-Feb-2021.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced TRAUMATIC HAEMATOMA (Hospital claimed "I had hematoma"), PERIPHERAL SWELLING (My foot swelled up enormously) and MOVEMENT DISORDER (Couldn't put my foot down on the floor in the morning). At the time of the report, TRAUMATIC HAEMATOMA (Hospital claimed "I had hematoma") and PERIPHERAL SWELLING (My foot swelled up enormously) had not resolved and MOVEMENT DISORDER (Couldn't put my foot down on the floor in the morning) outcome was unknown.        This case was linked to MOD-2021-075169 (Patient Link).
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Feeling abnormal, Vomiting
Clinical narrative: Diarrhea; Vomited about 5 times; Felt like crap; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), FEELING ABNORMAL (Felt like crap) and VOMITING (Vomited about 5 times) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A and 027A21A) for COVID-19 vaccination.     The patient's past medical history included Surgery (a long time ago).   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021 at 10:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced FEELING ABNORMAL (Felt like crap). On 10-Apr-2021 at 11:00 AM, the patient experienced VOMITING (Vomited about 5 times). On 11-Apr-2021, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea), FEELING ABNORMAL (Felt like crap) and VOMITING (Vomited about 5 times) outcome was unknown.            No relevant concomitant medications were provided. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Swelling arm of injection; Sore arm of injection; itchy at site of injection; Pinkish at site of injection; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING, PAIN IN EXTREMITY, VACCINATION SITE PRURITUS, and VACCINATION SITE ERYTHEMA in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced PERIPHERAL SWELLING, PAIN IN EXTREMITY, VACCINATION SITE PRURITUS, and VACCINATION SITE ERYTHEMA. At the time of the report, PERIPHERAL SWELLING, PAIN IN EXTREMITY, VACCINATION SITE PRURITUS, and VACCINATION SITE ERYTHEMA outcome was unknown. Not Provided          No relevant concomitant medications were provided.  The patient was inquiring if the polio vaccine interfere with the Covid-19 vaccination. Further, the patient stated that she had a medical appointment on 15-Apr-2021 to receive an injection. No treatment information was provided.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dehydration, Fatigue, Influenza like illness, Muscle fatigue
Clinical narrative: Body aches; Muscles tired with a heavy; Flu like symptoms; Weak; Muscle aches; Nausea; Fatigued; Almost fainted; Felt dehydrated; Weak legs; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRESYNCOPE (Almost fainted), DEHYDRATION (Felt dehydrated), MUSCULAR WEAKNESS (Weak legs), PAIN (Body aches) and MUSCLE FATIGUE (Muscles tired with a heavy) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced MUSCULAR WEAKNESS (Weak legs). On 10-Apr-2021, the patient experienced PRESYNCOPE (Almost fainted), DEHYDRATION (Felt dehydrated), PAIN (Body aches), MUSCLE FATIGUE (Muscles tired with a heavy), INFLUENZA LIKE ILLNESS (Flu like symptoms), ASTHENIA (Weak), MYALGIA (Muscle aches), NAUSEA (Nausea) and FATIGUE (Fatigued). At the time of the report, PRESYNCOPE (Almost fainted), DEHYDRATION (Felt dehydrated), MUSCULAR WEAKNESS (Weak legs), PAIN (Body aches), MUSCLE FATIGUE (Muscles tired with a heavy), INFLUENZA LIKE ILLNESS (Flu like symptoms), ASTHENIA (Weak), MYALGIA (Muscle aches), NAUSEA (Nausea) and FATIGUE (Fatigued) outcome was unknown. Not Provided          Concomitant medication not provided. Treatment was not included.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Myalgia, Nausea, Pain, Presyncope
Clinical narrative: Body aches; Muscles tired with a heavy; Flu like symptoms; Weak; Muscle aches; Nausea; Fatigued; Almost fainted; Felt dehydrated; Weak legs; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRESYNCOPE (Almost fainted), DEHYDRATION (Felt dehydrated), MUSCULAR WEAKNESS (Weak legs), PAIN (Body aches) and MUSCLE FATIGUE (Muscles tired with a heavy) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced MUSCULAR WEAKNESS (Weak legs). On 10-Apr-2021, the patient experienced PRESYNCOPE (Almost fainted), DEHYDRATION (Felt dehydrated), PAIN (Body aches), MUSCLE FATIGUE (Muscles tired with a heavy), INFLUENZA LIKE ILLNESS (Flu like symptoms), ASTHENIA (Weak), MYALGIA (Muscle aches), NAUSEA (Nausea) and FATIGUE (Fatigued). At the time of the report, PRESYNCOPE (Almost fainted), DEHYDRATION (Felt dehydrated), MUSCULAR WEAKNESS (Weak legs), PAIN (Body aches), MUSCLE FATIGUE (Muscles tired with a heavy), INFLUENZA LIKE ILLNESS (Flu like symptoms), ASTHENIA (Weak), MYALGIA (Muscle aches), NAUSEA (Nausea) and FATIGUE (Fatigued) outcome was unknown. Not Provided          Concomitant medication not provided. Treatment was not included.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 030B21A) for COVID-19 vaccination.     Concurrent medical conditions included COPD. Concomitant products included LISINOPRIL and HYDROXYZINE for an unknown indication.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage unit. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.            Concomitant products also included inhaler for COPD.  No treatment information was provided.   This case was linked to MOD-2021-075204 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Asthenia, Dehydration, Feeding disorder, Headache, Myalgia
Clinical narrative: headache; dehydrated; debilitated; sleeping; aching; couldn't eat; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (debilitated), SOMNOLENCE (sleeping), MYALGIA (aching), FEEDING DISORDER (couldn't eat) and HEADACHE (headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Multiple sclerosis.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (debilitated), SOMNOLENCE (sleeping), MYALGIA (aching), FEEDING DISORDER (couldn't eat), HEADACHE (headache) and DEHYDRATION (dehydrated). At the time of the report, ASTHENIA (debilitated), SOMNOLENCE (sleeping), MYALGIA (aching), FEEDING DISORDER (couldn't eat), HEADACHE (headache) and DEHYDRATION (dehydrated) outcome was unknown. Not Provided          No concomitant medications provided.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: headache; dehydrated; debilitated; sleeping; aching; couldn't eat; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (debilitated), SOMNOLENCE (sleeping), MYALGIA (aching), FEEDING DISORDER (couldn't eat) and HEADACHE (headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Multiple sclerosis.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (debilitated), SOMNOLENCE (sleeping), MYALGIA (aching), FEEDING DISORDER (couldn't eat), HEADACHE (headache) and DEHYDRATION (dehydrated). At the time of the report, ASTHENIA (debilitated), SOMNOLENCE (sleeping), MYALGIA (aching), FEEDING DISORDER (couldn't eat), HEADACHE (headache) and DEHYDRATION (dehydrated) outcome was unknown. Not Provided          No concomitant medications provided.   Reporter did not allow further contact
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Pain in extremity, Somnolence
Clinical narrative: sick in her stomach all day long; Stayed in bed all day; pain in arm; chills; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (sick in her stomach all day long), SOMNOLENCE (Stayed in bed all day), PAIN IN EXTREMITY (pain in arm) and CHILLS (chills) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037132AA and 044821A) for COVID-19 vaccination.     Concurrent medical conditions included Eczema and Back disorder. Concomitant products included TRIAMCINOLONE and MELOXICAM for an unknown indication.   On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Apr-2021, the patient experienced ABDOMINAL DISCOMFORT (sick in her stomach all day long), SOMNOLENCE (Stayed in bed all day), PAIN IN EXTREMITY (pain in arm) and CHILLS (chills). At the time of the report, ABDOMINAL DISCOMFORT (sick in her stomach all day long), SOMNOLENCE (Stayed in bed all day), PAIN IN EXTREMITY (pain in arm) and CHILLS (chills) outcome was unknown.            No treatment information was provided.   This case was linked to MOD-2021-053095 (Patient Link).
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 17 year old vaccinated; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old vaccinated) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old vaccinated). On 25-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old vaccinated) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were provided.  Reportedly, no other side effects reported and the patient did not receive any treatment.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Pain in extremity
Clinical narrative: Second shot on 38th day (after first shot); Sore arm  after second shot; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm  after second shot) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second shot on 38th day (after first shot)) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030B21A and 036A21A) for COVID-19 vaccination.     Concurrent medical conditions included COPD. Concomitant products included LISINOPRIL and HYDROXYZINE for an unknown indication.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second shot on 38th day (after first shot)). In April 2021, the patient experienced PAIN IN EXTREMITY (Sore arm  after second shot). On 12-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second shot on 38th day (after first shot)) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm  after second shot) was resolving.            Concomitant product also included inhaler for COPD.  No treatment information was provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine)  was Not applicable.   This case was linked to MOD-2021-075197 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Hyperhidrosis, Nausea
Clinical narrative: Sweating; Swollen arm; 103 F. fever; Chills; Nausea; Voimiting; Tired; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating), PERIPHERAL SWELLING (Swollen arm), PYREXIA (103 F. fever), CHILLS (Chills) and NAUSEA (Nausea) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027B21A and 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced HYPERHIDROSIS (Sweating), PERIPHERAL SWELLING (Swollen arm), PYREXIA (103 F. fever), CHILLS (Chills), NAUSEA (Nausea), VOMITING (Voimiting) and FATIGUE (Tired). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. In April 2021, HYPERHIDROSIS (Sweating), PERIPHERAL SWELLING (Swollen arm), PYREXIA (103 F. fever), CHILLS (Chills), NAUSEA (Nausea), VOMITING (Voimiting) and FATIGUE (Tired) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Apr-2021, Body temperature: 103 f (High) 103 F.         No relevant concomitant medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Events end date and outcome added.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pyrexia, Vomiting
Clinical narrative: Sweating; Swollen arm; 103 F. fever; Chills; Nausea; Voimiting; Tired; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating), PERIPHERAL SWELLING (Swollen arm), PYREXIA (103 F. fever), CHILLS (Chills) and NAUSEA (Nausea) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027B21A and 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced HYPERHIDROSIS (Sweating), PERIPHERAL SWELLING (Swollen arm), PYREXIA (103 F. fever), CHILLS (Chills), NAUSEA (Nausea), VOMITING (Voimiting) and FATIGUE (Tired). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. In April 2021, HYPERHIDROSIS (Sweating), PERIPHERAL SWELLING (Swollen arm), PYREXIA (103 F. fever), CHILLS (Chills), NAUSEA (Nausea), VOMITING (Voimiting) and FATIGUE (Tired) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Apr-2021, Body temperature: 103 f (High) 103 F.         No relevant concomitant medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Events end date and outcome added.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Warm to the touch; Itchiness at the injection site/ more of an itch; Light swelling at the injection site; Rash at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to the touch), VACCINATION SITE PRURITUS (Itchiness at the injection site/ more of an itch), VACCINATION SITE SWELLING (Light swelling at the injection site) and VACCINATION SITE RASH (Rash at the injection site) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included LOSARTAN POTASSIUM (LOSARTIN), ROSUVASTATIN and AMLODIPINE for an unknown indication.    On 06-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced VACCINATION SITE WARMTH (Warm to the touch), VACCINATION SITE PRURITUS (Itchiness at the injection site/ more of an itch), VACCINATION SITE SWELLING (Light swelling at the injection site) and VACCINATION SITE RASH (Rash at the injection site). On 13-Apr-2021, VACCINATION SITE SWELLING (Light swelling at the injection site) had resolved. At the time of the report, VACCINATION SITE WARMTH (Warm to the touch) and VACCINATION SITE PRURITUS (Itchiness at the injection site/ more of an itch) had not resolved and VACCINATION SITE RASH (Rash at the injection site) outcome was unknown.            No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Arm  was really sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm  was really sore at the injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced VACCINATION SITE PAIN (Arm  was really sore at the injection site). At the time of the report, VACCINATION SITE PAIN (Arm  was really sore at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided.  No treatment information was provided.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: Rash close to the elbow, that itches but doesn't hurt; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Rash close to the elbow, that itches but doesn't hurt) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced RASH PRURITIC (Rash close to the elbow, that itches but doesn't hurt). At the time of the report, RASH PRURITIC (Rash close to the elbow, that itches but doesn't hurt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Testing positive for covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Testing positive for covid-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced COVID-19 (Testing positive for covid-19). On 10-Apr-2021, COVID-19 (Testing positive for covid-19) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Apr-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided.  No treatment information was provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Vaccination site pain
Clinical narrative: Inappropriate schedule of dose; sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore left arm) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of dose) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004MZ0A) for COVID-19 vaccination.     No medical history was provided by reporter.  No concomitant medication reported.    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Dec-2020, the patient experienced VACCINATION SITE PAIN (sore left arm). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of dose). At the time of the report, VACCINATION SITE PAIN (sore left arm) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of dose) outcome was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Abnormal sensation in eye, Anxiety, Arthritis, Fatigue, Headache
Clinical narrative: eyes were burning while she was watching TV; Fever; throwed up a lot; she didn't sleep much; couldn't calm herself down.; probably had all the general symptoms of the flue; arthritis acted up; headache; fatigued; This spontaneous case was reported by a patient and describes the occurrence of ARTHRITIS (arthritis acted up), ABNORMAL SENSATION IN EYE (eyes were burning while she was watching TV), INFLUENZA LIKE ILLNESS (probably had all the general symptoms of the flue), INSOMNIA (she didn't sleep much) and ANXIETY (couldn't calm herself down.) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Depression, Anxiety and Knee replacement. Concomitant products included ALPRAZOLAM (XANAX), VENLAFAXINE HYDROCHLORIDE (EFFEXOR), ATORVASTATIN CALCIUM (LIPITOR) and VITAMINS NOS for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced ARTHRITIS (arthritis acted up), INFLUENZA LIKE ILLNESS (probably had all the general symptoms of the flue), HEADACHE (headache) and FATIGUE (fatigued). On 03-Apr-2021, the patient experienced INSOMNIA (she didn't sleep much) and ANXIETY (couldn't calm herself down.). On 05-Apr-2021, the patient experienced VOMITING (throwed up a lot). On 10-Apr-2021, the patient experienced ABNORMAL SENSATION IN EYE (eyes were burning while she was watching TV) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency; IBUPROFEN for Headache, at an unspecified dose and frequency and CANNABIDIOL at an unspecified dose and frequency. On 04-Apr-2021, INSOMNIA (she didn't sleep much) and ANXIETY (couldn't calm herself down.) had resolved. On 05-Apr-2021, VOMITING (throwed up a lot) had resolved. At the time of the report, ARTHRITIS (arthritis acted up), ABNORMAL SENSATION IN EYE (eyes were burning while she was watching TV), INFLUENZA LIKE ILLNESS (probably had all the general symptoms of the flue), PYREXIA (Fever), HEADACHE (headache) and FATIGUE (fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment: The patient stated she had Ibuprofen and acetaminophen (Tylenol) but they do not help. Now the patient is using cannabidiol (CBD) tablets that help a little - it has cannabigerol (CBG).
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Insomnia, Pyrexia, Vomiting
Clinical narrative: eyes were burning while she was watching TV; Fever; throwed up a lot; she didn't sleep much; couldn't calm herself down.; probably had all the general symptoms of the flue; arthritis acted up; headache; fatigued; This spontaneous case was reported by a patient and describes the occurrence of ARTHRITIS (arthritis acted up), ABNORMAL SENSATION IN EYE (eyes were burning while she was watching TV), INFLUENZA LIKE ILLNESS (probably had all the general symptoms of the flue), INSOMNIA (she didn't sleep much) and ANXIETY (couldn't calm herself down.) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Depression, Anxiety and Knee replacement. Concomitant products included ALPRAZOLAM (XANAX), VENLAFAXINE HYDROCHLORIDE (EFFEXOR), ATORVASTATIN CALCIUM (LIPITOR) and VITAMINS NOS for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced ARTHRITIS (arthritis acted up), INFLUENZA LIKE ILLNESS (probably had all the general symptoms of the flue), HEADACHE (headache) and FATIGUE (fatigued). On 03-Apr-2021, the patient experienced INSOMNIA (she didn't sleep much) and ANXIETY (couldn't calm herself down.). On 05-Apr-2021, the patient experienced VOMITING (throwed up a lot). On 10-Apr-2021, the patient experienced ABNORMAL SENSATION IN EYE (eyes were burning while she was watching TV) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency; IBUPROFEN for Headache, at an unspecified dose and frequency and CANNABIDIOL at an unspecified dose and frequency. On 04-Apr-2021, INSOMNIA (she didn't sleep much) and ANXIETY (couldn't calm herself down.) had resolved. On 05-Apr-2021, VOMITING (throwed up a lot) had resolved. At the time of the report, ARTHRITIS (arthritis acted up), ABNORMAL SENSATION IN EYE (eyes were burning while she was watching TV), INFLUENZA LIKE ILLNESS (probably had all the general symptoms of the flue), PYREXIA (Fever), HEADACHE (headache) and FATIGUE (fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment: The patient stated she had Ibuprofen and acetaminophen (Tylenol) but they do not help. Now the patient is using cannabidiol (CBD) tablets that help a little - it has cannabigerol (CBG).
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Minor Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 026B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MULTIVITAMIN.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced PAIN IN EXTREMITY. On 04-Mar-2021, PAIN IN EXTREMITY had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Treatment information was not provided.   This case was linked to MOD-2021-075218.   Most recent FOLLOW-UP information incorporated above included  On 05-May-2021: Reporter's contact information updated. Concomitant medication updated.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Pregnancy test
Clinical narrative: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 35-year-old female patient (gravida 1, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Allergic to Percocet), Hypothyroidism since 2005 and Allergy to antibiotic (Allergic to Augmentin). Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) and THYROID (ARMOUR THYROID) for an unknown indication.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 03-Oct-2020 and the estimated date of delivery was 10-Jul-2021. On 13-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fourteenth week of the pregnancy.  On 13-Jan-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Nov-2020, Pregnancy test: positive (Positive) Positive.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       The number of previous pregnancies included one full term birth on 29-May-2019. Positive pregnancy date was 01-Nov-2020
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: Sick for 1.5 week after receiving vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick for 1.5 week after receiving vaccine) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced ILLNESS (Sick for 1.5 week after receiving vaccine). At the time of the report, ILLNESS (Sick for 1.5 week after receiving vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications and treatment information were not provided.   This case was linked to MOD-2021-075267, MOD-2021-075275, MOD-2021-075286 (E2B Linked Report).; Sender's Comments:  MOD-2021-075267:Crosslink - same reporter MOD-2021-075275:Crosslink - same reporter MOD-2021-075286:Crosslink - same reporter
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Dizziness, Injection site muscle weakness, Vaccination site pain
Clinical narrative: felt weird light-headed; Felt not balanced; felt weak too in the arm at the site of the injection in the left arm; felt like someone punched their arm  at the site of the injection in the left arm; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (felt weird light-headed), BALANCE DISORDER (Felt not balanced), INJECTION SITE MUSCLE WEAKNESS (felt weak too in the arm at the site of the injection in the left arm) and VACCINATION SITE PAIN (felt like someone punched their arm  at the site of the injection in the left arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for Pain.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced DIZZINESS (felt weird light-headed), BALANCE DISORDER (Felt not balanced), INJECTION SITE MUSCLE WEAKNESS (felt weak too in the arm at the site of the injection in the left arm) and VACCINATION SITE PAIN (felt like someone punched their arm  at the site of the injection in the left arm). At the time of the report, DIZZINESS (felt weird light-headed), BALANCE DISORDER (Felt not balanced), INJECTION SITE MUSCLE WEAKNESS (felt weak too in the arm at the site of the injection in the left arm) and VACCINATION SITE PAIN (felt like someone punched their arm  at the site of the injection in the left arm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient stated the symptoms started about 15 to 20 minutes after they left the vaccination site. The symptoms were gone two hours later. No medications were taken to help with the symptoms.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness postural, Pyrexia
Clinical narrative: when I laid down I had dizziness. The dizziness was more intense when I was lying; low grade fever; This spontaneous case was reported by a patient and describes the occurrence of DIZZINESS POSTURAL (when I laid down I had dizziness. The dizziness was more intense when I was lying) and PYREXIA (low grade fever) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 025A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced DIZZINESS POSTURAL (when I laid down I had dizziness. The dizziness was more intense when I was lying) and PYREXIA (low grade fever). At the time of the report, DIZZINESS POSTURAL (when I laid down I had dizziness. The dizziness was more intense when I was lying) and PYREXIA (low grade fever) had resolved.            No concomitant medications were reported.   No treatment information was provided.   This case was linked to MOD-2021-075203 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Follow up was received Patient demographics were added email address were added
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash looks like rash of poison Ivy that patient had developed before when he was exposed to poison ivy.; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash looks like rash of poison Ivy that patient had developed before when he was exposed to poison ivy.) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Poison ivy rash.    On 09-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced RASH (rash looks like rash of poison Ivy that patient had developed before when he was exposed to poison ivy.). At the time of the report, RASH (rash looks like rash of poison Ivy that patient had developed before when he was exposed to poison ivy.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications and treatment information were not provided.